Bluejay Diagnostics, Inc. 8-K

What Happened

• Bluejay Diagnostics, Inc. (BJDX) filed a Form 8-K on March 12, 2026 to report a Regulation FD disclosure. The company issued a press release dated March 12, 2026 stating that an abstract related to its product candidate, the Symphony™ IL-6 Test, was accepted for presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting.

Key Details

• Filing date: March 12, 2026 (Form 8-K, Item 7.01).
• Event: Abstract acceptance for presentation at the 2026 SAEM Annual Meeting.
• Product: Symphony™ IL-6 Test (product candidate referenced in the abstract).
• The press release is furnished as Exhibit 99.1 to the Form 8-K.

Why It Matters

• The filing notifies investors that Bluejay’s Symphony IL-6 Test will be discussed at a recognized emergency medicine conference, which can increase the product’s visibility among clinicians and researchers. This is an informational disclosure under Regulation FD; investors should watch for any forthcoming presentation details or data releases that could provide more substantive clinical or regulatory information.